Document:

THIS
NOTE MAY NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED, HYPOTHECATED OR OTHERWISE ALIENATED OR ENCUMBERED WITHOUT THE PRIOR WRITTEN
CONSENT OF INVESTOR.

 

	 

        $
	State
        of ______

        _____________,
        2014

 

INVESTOR
NOTE #1

 

FOR
VALUE RECEIVED, ________________, a ______________________ (“Investor”),
hereby promises to pay to Endeavor IP, Inc., a Nevada corporation (“Company”,
and together with Investor, the “Parties”), the principal sum of $___________ together with all accrued and
unpaid interest thereon, fees incurred or other amounts owing hereunder, all as set forth below in this Investor Note #1 (this
“Note”). This Note is issued pursuant to that certain Securities Purchase Agreement of even date herewith,
entered into by and between Investor and Company (as the same may be amended from time to time, the “Purchase Agreement”),
pursuant to which Company issued to Investor that certain Secured Convertible Promissory Note in the principal amount of $_________________
(as the same may be amended from time to time, the “Company Note”) convertible into shares of Company’s
Common Stock. All capitalized terms used but not otherwise defined herein shall have the meanings ascribed thereto in the Purchase
Agreement.

 

1.                 
Principal and Interest. Interest shall accrue on the unpaid principal balance and any unpaid late fees or other fees under
this Note at a rate of eight percent (8.0%) per annum until the full amount of the principal and fees has been paid. Interest
shall be computed on the basis of a 365-day year for the actual number of days elapsed. Notwithstanding any provision to the contrary
herein, in no event shall the applicable interest rate at any time exceed the maximum interest rate allowed under applicable law,
as provided in Section 12 below. The entire unpaid principal balance and all accrued and unpaid interest, if any, under this Note,
shall be due and payable on the date that is seventeen (17) months from the date hereof (the “Investor Note Maturity
Date”); provided, however, that Investor may elect, in its sole discretion, to extend the Investor Note Maturity
Date for up to thirty (30) days by delivering written notice of such election to Company at any time prior to the Investor Note
Maturity Date.

 

2.                 
Payment. Unless prepaid, all principal and accrued interest under this Note is payable in one lump sum on the Investor
Note Maturity Date. All payments of interest and principal shall be (i) in lawful money of the United States of America, and (ii)
in the form of immediately available funds. All payments shall be applied first to costs of collection, if any, then to accrued
and unpaid interest, and thereafter to principal. Payment of principal and interest hereunder shall be delivered to Company at
the address furnished to Investor for that purpose.

 

3.                 
Prepayment by Investor. Investor may, in its sole and absolute discretion, pay, without penalty, all or any portion of
the outstanding balance along with any accrued but unpaid interest on this Note at any time prior to the Investor Note Maturity
Date.

 

4.                 
Security; Collateral. Investor may, in its sole discretion, designate collateral (the “Collateral”)
as it deems fit, as security for Investor’s obligations hereunder, which Collateral may be, but is not required to be, real
property, a letter of credit with a financial institution determined by Investor in its sole discretion, or pledged membership
interests, provided that the net fair market value of the Collateral (net of any outstanding monetary liens) shall not be less
than the principal balance of this Note as of the date of any such designation. Upon Investor’s designation of Collateral,
each of Investor and Company shall timely execute any and all documents necessary or advisable in order to properly grant a security
interest upon the Collateral in favor of Company.

 

5.                 
Release. Company covenants and agrees that in the event that this Note is secured by Collateral, Company shall timely execute
any and all documents necessary or advisable in order to release such security interest and Collateral to Investor, or Investor’s
designee, upon the earlier of (i) the date this Note is paid in full and (ii) the date that is six (6) months and three (3) days
following the date such Collateral is given as security for this Note, or such later date as determined in the sole discretion
of Investor (the “Release Date”). For avoidance of doubt, as of the date hereof, there is no collateral securing
this Note, and after the Release Date, as applicable, there shall be no collateral securing this Note.

 

6.                 
Right of Offset. Notwithstanding anything to the contrary herein or in any of the other Transaction Documents, in the event
(i) of the occurrence of any Event of Default (as defined in the Company Note) under the Company Note or any other note issued
by Company in connection with the Purchase Agreement, (ii) Investor applies a Default Effect (as defined in the Company Note)
under the Company Note, (iii) the Outstanding Balance is automatically increased to the Mandatory Default Amount under the Company
Note, (iv) the Company Note is accelerated for any reason, or (v) of a breach of any material term, condition, representation,
warranty, covenant or obligation of Company under any Transaction Document; Investor shall be entitled to deduct and offset any
amount owing by Company under the Company Note from any amount owed by Investor under this Note (the “Investor Offset
Right”), provided that if any of the foregoing events occur and Investor has not yet exercised the Investor Offset Right,
the Investor Offset Right shall be automatically exercised on the date that is thirty (30) days prior to the Investor Note Maturity
Date. In the event that Investor’s exercise of the Investor Offset Right under this Section 6 results in the full satisfaction
of Investor’s obligations under this Note, then Company shall return this Note to Investor for cancellation or, in the event
this Note has been lost, stolen or destroyed, Company shall provide Investor with a lost note affidavit in a form reasonably acceptable
to Investor.

 

7.                 
Default. If any of the events specified below shall occur (each, an “Investor Note Default”) Company
may declare the unpaid principal balance under this Note, together with all accrued and unpaid interest thereon, fees incurred
or other amounts owing hereunder immediately due and payable, by notice in writing to Investor. If any default, other than a Payment
Default (as defined below), is curable, then the default may be cured (and no Investor Note Default will have occurred) if Investor,
after receiving written notice from Company demanding cure of such default, either (a) cures the default within fifteen (15) days
of the receipt of such notice, or (b) if the cure requires more than fifteen (15) days, immediately initiates steps that Company
deems in Company’s reasonable discretion to be sufficient to cure the default and thereafter diligently continues and completes
all reasonable and necessary steps sufficient to produce compliance as soon as reasonably practical. Each of the following events
shall constitute an Investor Note Default:

 

7.1.           
Failure to Pay. Investor’s failure to make any payment when due and payable under this Note (a “Payment
Default”);

 

7.2.           
Breaches of Covenants. Investor’s failure to observe or perform any other covenant, obligation, condition or agreement
contained in this Note;

 

    	1

    	 

    

 

7.3.           
Representations and Warranties. If any representation, warranty, certificate, or other statement (financial or otherwise)
made or furnished by or on behalf of Investor to Company in writing in connection with this Note or any of the other Transaction
Documents, or as an inducement to Company to enter into the Purchase Agreement, shall be false or misleading in any material respect
when made or furnished; and

 

7.4.           
Involuntary Bankruptcy. If any involuntary petition is filed under any bankruptcy or similar law or rule against Investor,
and such petition is not dismissed within sixty (60) days, or a receiver, trustee, liquidator, assignee, custodian, sequestrator
or other similar official is appointed to take possession of any of the assets or properties of Investor.

 

8.                 
Binding Effect; Assignment. This Note shall be binding on the Parties and their respective heirs, successors, and assigns;
provided, however, that neither party shall assign any of its rights hereunder without the prior written consent
of the other party, except that Investor may assign this Note to any of its Affiliates without the prior written consent of Company
and, furthermore, Company agrees that it shall not unreasonably withhold, condition or delay its consent to any other assignment
of this Note by Investor.

 

9.                 
Governing Law. This Note shall be governed by and interpreted in accordance with the laws of the State of Utah for contracts
to be wholly performed in such state and without giving effect to the principles thereof regarding the conflict of laws.

 

10.             
Purchase Agreement; Arbitration of Disputes. By acceptance of this Note, each party agrees to be bound by the applicable
terms, conditions and general provisions of the Purchase Agreement and the other Transaction Documents, including without limitation
the Arbitration Provisions attached as an Exhibit to the Purchase Agreement.

 

11.             
Customer Identification–USA Patriot Act Notice. Company hereby notifies Investor that pursuant to the requirements
of the USA Patriot Act (Title III of Pub. L. 107-56, signed into law October 26, 2001) (the “Act”), and Company’s
policies and practices, Company is required to obtain, verify and record certain information and documentation that identifies
Investor, which information includes the name and address of Investor and such other information that will allow Company to identify
Investor in accordance with the Act.

 

12.             
Lawful Interest. It being the intention of Company and Investor to comply with all applicable laws with regard to the interest
charged hereunder, it is agreed that, notwithstanding any provision to the contrary in this Note or any of the other Transaction
Documents, no such provision, including without limitation any provision of this Note providing for the payment of interest or
other charges, shall require the payment or permit the collection of any amount in excess of the maximum amount of interest permitted
by law to be charged for the use or detention, or the forbearance in the collection, of all or any portion of the indebtedness
evidenced by this Note or by any extension or renewal hereof (“Excess Interest”). If any Excess Interest is
provided for, or is adjudicated to be provided for, in this Note, then in such event:

 

12.1.       
the provisions of this Section 12 shall govern and control;

 

12.2.       
Investor shall not be obligated to pay any Excess Interest;

 

12.3.       
any Excess Interest that Company may have received hereunder shall, at the option of Company, be (i) applied as a credit against
the principal balance due under this Note or the accrued and unpaid interest thereon not to exceed the maximum amount permitted
by law, or both, (ii) refunded to Investor, or (iii) any combination of the foregoing;

 

12.4.       
the applicable interest rate or rates shall be automatically subject to reduction to the maximum lawful rate allowed to be contracted
for in writing under the applicable governing usury laws, and this Note and the Transaction Documents shall be deemed to have
been, and shall be, reformed and modified to reflect such reduction in such interest rate or rates; and

 

12.5.       
Investor shall not have any action or remedy against Company for any damages whatsoever or any defense to enforcement of this
Note or arising out of the payment or collection of any Excess Interest.

 

13.             
Pronouns. Regardless of their form, all words used in this Note shall be deemed singular or plural and shall have the gender
as required by the text.

 

14.             
Headings. The various headings used in this Note as headings for sections or otherwise are for convenience and reference
only and shall not be used in interpreting the text of the section in which they appear and shall not limit or otherwise affect
the meanings thereof.

 

15.             
Time of Essence. Time is of the essence with this Note.

 

16.             
Severability. If any part of this Note is construed to be in violation of any law, such part shall be modified to achieve
the objective of the Parties to the fullest extent permitted by law and the balance of this Note shall remain in full force and
effect.

    	2

    	 

    

 

 

17.             
Attorneys’ Fees. If any arbitration or action at law or in equity is necessary to enforce this Note or to collect
payment under this Note, Company shall be entitled to recover reasonable attorneys’ fees directly related to such enforcement
or collection actions.

 

18.             
Amendments and Waivers; Remedies. No failure or delay on the part of either party hereto in exercising any right, power
or remedy hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such right, power or remedy
preclude any other or further exercise thereof or the exercise of any other right, power or remedy. The remedies provided for
herein are cumulative and are not exclusive of any remedies that may be available to either party hereto at law, in equity or
otherwise. Any amendment, supplement or modification of or to any provision of this Note, any waiver of any provision of this
Note, and any consent to any departure by either party from the terms of any provision of this Note, shall be effective (i) only
if it is made or given in writing and signed by Investor and Company and (ii) only in the specific instance and for the specific
purpose for which made or given.

 

19.             
Notices. Unless otherwise provided for herein, all notices, requests, demands, claims and other communications hereunder
shall be given in accordance with the subsection of the Purchase Agreement titled “Notices.” Either party may change
the address to which notices, requests, demands, claims and other communications hereunder are to be delivered by providing notice
thereof in the manner set forth in the Purchase Agreement.

 

20.             
Final Note. This Note, together with the other Transaction Documents, contains the complete understanding and agreement
of Investor and Company and supersedes all prior representations, warranties, agreements, arrangements, understandings, and negotiations
of Investor and Company with respect to the subject matter of the Transaction Documents. THIS NOTE, TOGETHER WITH THE OTHER TRANSACTION
DOCUMENTS, REPRESENTS THE FINAL AGREEMENT BETWEEN THE PARTIES AND MAY NOT BE CONTRADICTED BY EVIDENCE OF ANY ALLEGED PRIOR, CONTEMPORANEOUS,
OR SUBSEQUENT ORAL AGREEMENTS OF THE PARTIES. THERE ARE NO UNWRITTEN ORAL AGREEMENTS BETWEEN THE PARTIES.

[Remainder
of page intentionally left blank; signature page follows]

 

    	3

    	 

    

 

IN
WITNESS WHEREOF, the Parties have executed this Note as of the date set forth above.

 

INVESTOR:

________________________

 

By:

 

By:

 

 

  

ACKNOWLEDGED,
ACCEPTED AND AGREED:

 

COMPANY:

Endeavor
IP, Inc.

 

By:

Name:

Title:

 

    	4THIS
WARRANT AND THE COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933,
AS AMENDED. THIS WARRANT AND THE COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED
OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THIS WARRANT UNDER SUCH ACT AND ANY APPLICABLE STATE
SECURITIES LAW OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO ENDEAVOR IP, INC. THAT SUCH REGISTRATION IS NOT REQUIRED.

 

ENDEAVOR
IP, INC.

 

WARRANT
TO PURCHASE SHARES OF COMMON STOCK

 

1.                 
Issuance. In consideration of good and valuable consideration as set forth in the Purchase Agreement (defined below), including
without limitation the Initial Cash Purchase Price (as defined in the Purchase Agreement), the receipt and sufficiency of which
are hereby acknowledged by Endeavor IP, Inc., a Nevada corporation (“Company”);
Typenex Co-Investment, LLC, a Utah limited liability company, its successors and/or
registered assigns (“Investor”), is hereby granted the right to purchase at any time on or after the Issue
Date (as defined below) until the date which is the last calendar day of the month in which the fifth anniversary of the Issue
Date occurs (the “Expiration Date”), a number of fully paid and non-assessable shares (the “Warrant
Shares”) of Company’s common stock, par value $0.0001 per share (the “Common Stock”), equal
to $139,500.00 divided by the Market Price (as defined in the Note, as of the Issue Date), as such number may be adjusted from
time to time pursuant to the terms and conditions of this Warrant to Purchase Shares of Common Stock (this “Warrant”).
This Warrant is being issued pursuant to the terms of that certain Securities Purchase Agreement dated July 16, 2014, to which
Company and Investor are parties (as the same may be amended from time to time, the “Purchase Agreement”).

 

Unless
otherwise indicated herein, capitalized terms not otherwise defined herein shall have the meanings ascribed to them in the Purchase
Agreement.

 

This
Warrant was originally issued to Investor on July 16, 2014 (the “Issue Date”).

 

2.                 
Exercise of Warrant.

 

2.1.           
General.

 

(a)               
This Warrant is exercisable in whole or in part at any time and from time to time commencing on the Issue Date and ending on the
Expiration Date. Such exercise shall be effectuated by submitting to Company (either by delivery to Company or by email or facsimile
transmission) a completed and duly executed Notice of Exercise substantially in the form attached to this Warrant as Exhibit
A (the “Notice of Exercise”). The date such Notice of Exercise is either faxed, emailed or delivered to
Company shall be the “Exercise Date,” provided that, if such exercise represents the full exercise of the outstanding
balance of the Warrant, Investor shall tender this Warrant to Company within five (5) Trading Days thereafter, but only if the
Warrant Shares to be delivered pursuant to the Notice of Exercise have been delivered to Investor as of such date. The Notice
of Exercise shall be executed by Investor and shall indicate (i) the number of Delivery Shares (as defined below) to be issued
pursuant to such exercise, and (ii) if applicable (as provided below), whether the exercise is a cashless exercise.

 

For
purposes of this Warrant, the term “Trading Day” means any day during which the principal market on which the
Common Stock is traded (the “Principal Market”) shall be open for business.

 

(b)              
Notwithstanding any other provision contained herein or in any other Transaction Document to the contrary, at any time prior to
the Expiration Date, Investor may elect a “cashless” exercise of this Warrant for any Warrant Shares whereby Investor
shall be entitled to receive a number of shares of Common Stock equal to (i) the excess of the Current Market Value (as defined
below) over the aggregate Exercise Price of the Exercise Shares (as defined below), divided by (ii) the Adjusted Price of the
Common Stock (as defined below).

 

For
the purposes of this Warrant, the following terms shall have the following meanings:

 

“Adjusted
Price of the Common Stock” shall mean the lower of (i) the Conversion Price (as defined in the Note), as such Conversion
Price may be adjusted from time to time pursuant to the terms of the Note (solely for the purpose of determining the then-current
Conversion Price under this definition of “Adjusted Price of the Common Stock,” each cashless exercise of this Warrant
shall be deemed a conversion under the Note), and (ii) the Market Price (as defined in the Note), without regard to whether the
Note remains outstanding or has been fully repaid, cancelled or otherwise retired, on any relevant Exercise Date.

 

“Current
Market Value” shall mean an amount equal to the Market Price of the Common Stock (as defined below), multiplied by the
number of Exercise Shares specified in the applicable Notice of Exercise.

 

“Closing
Price” shall mean the 4:00 P.M. last sale price of the Common Stock on the Principal Market on the relevant Trading
Day(s), as reported by Bloomberg LP (or if that service is not then reporting the relevant information regarding the Common Stock,
a comparable reporting service of national reputation selected by Investor and reasonably acceptable to Company) (“Bloomberg”)
for the relevant date.

 

“Delivery
Shares” means those shares of Common Stock issuable and deliverable upon the exercise of this Warrant.

 

“Exercise
Price” shall mean $0.06 per share of Common Stock, as the same may be adjusted from time to time pursuant to the terms
and conditions of this Warrant.

 

    	 

    	 

    

 

“Exercise
Shares” shall mean those Warrant Shares subject to an exercise of the Warrant by Investor. By way of illustration only
and without limiting the foregoing, if (i) the Warrant is initially exercisable for 4,180,000 Warrant Shares and Investor has
not previously exercised the Warrant, and (ii) Investor were to make a cashless exercise with respect to 5,000 Warrant Shares
pursuant to which 6,000 Delivery Shares would be issuable to Investor, then (1) the Warrant shall be deemed to have been exercised
with respect to 5,000 Exercise Shares, (2) the Warrant would remain exercisable for 4,175,000 Warrant Shares, and (3) the Warrant
shall be deemed to have been exercised with respect to 6,000 Delivery Shares.

 

“Market
Price of the Common Stock” shall mean the higher of: (i) the Closing Price of the Common Stock on the Issue Date; and
(ii) the VWAP (as defined below) of the Common Stock for the Trading Day that is two (2) Trading Days prior to the Exercise Date.

 

“Note”
shall mean that certain Secured Convertible Promissory Note issued by Company to Investor pursuant to the Purchase Agreement,
as the same may be amended from time to time, and including any promissory note(s) that replace or are exchanged for such referenced
promissory note.

 

“Transaction
Documents” or “Transaction Document” shall have the meaning set forth in the Purchase Agreement.

 

“VWAP”
shall mean the volume-weighted average price of the Common Stock on the Principal Market for a particular Trading Day or set of
Trading Days, as the case may be, as reported by Bloomberg.

 

(c)               
If the Notice of Exercise form elects a “cash” exercise (or if the cashless exercise referred to in the immediately
preceding subsection (b) is not available in accordance with the terms hereof), the Exercise Price per share of Common Stock for
the Delivery Shares shall be payable, at the election of Investor, in cash or by certified or official bank check or by wire transfer
in accordance with instructions provided by Company at the request of Investor.

 

(d)              
Upon the appropriate payment to Company, if any, of the Exercise Price for the Delivery Shares, Company shall promptly, but in
no case later than the date that is three (3) Trading Days following the date the Exercise Price is paid to Company (or with respect
to a “cashless exercise,” the date that is three (3) Trading Days following the Exercise Date) (the “Delivery
Date”), provided that the Common Stock is then DTC Eligible (as defined in the Note), deliver or cause Company’s
Transfer Agent (as defined in the Note) to deliver to Investor or its broker (as designated in the Notice of Exercise), via reputable
overnight courier, a certificate, registered in the name of Investor or its designee, representing DTC Eligible Common Stock equal
to the applicable number of Delivery Shares. If the Common Stock is not DTC Eligible at such time, such shall constitute a breach
of this Warrant (and thus an Event of Default under the Note), and Company shall instead, on or before the applicable date set
forth above in this subsection, issue and deliver to Investor or its broker (as designated in the Notice of Exercise), via reputable
overnight courier, a certificate, registered in the name of Investor or its designee, representing the applicable number of Delivery
Shares. For the avoidance of doubt, Company has not met its obligation to deliver Delivery Shares within the required timeframe
set forth above unless Investor or its broker, as applicable, has actually received the certificate representing the applicable
Delivery Shares no later than the close of business on the latest possible delivery date pursuant to the terms set forth above.

 

(e)               
If Delivery Shares are delivered later than as required under subsection (d) immediately above, Company agrees to pay, in addition
to all other remedies available to Investor in the Transaction Documents, a late charge equal to the greater of (i) $500.00 and
(ii) 2% of the product of (1) the sum of the number of shares of Common Stock not issued to Investor on a timely basis and
to which Investor is entitled multiplied by (2) the closing bid price of the Common Stock on the Trading Day immediately
preceding the last possible date which Company could have issued such shares of Common Stock to Investor without violating this
Warrant, per Trading Day until such Delivery Shares are delivered (the “Late Fees”). Company shall pay any
Late Fees incurred under this subsection in immediately available funds upon demand; provided, however, that, at the option
of Investor (without notice to Company), such amount owed may be added to the principal amount of the Note. Furthermore, in addition
to any other remedies which may be available to Investor, in the event that Company fails for any reason to effect delivery of
the Delivery Shares as required under subsection (d) immediately above, Investor may revoke all or part of the relevant Warrant
exercise by delivery of a notice to such effect to Company, whereupon Company and Investor shall each be restored to their respective
positions immediately prior to the exercise of the relevant portion of this Warrant, except that the Late Fees described above
shall be payable through the date notice of revocation or rescission is given to Company. Finally, as liquidated damages in the
event Company fails to deliver any Delivery Shares to Investor for a period of ninety (90) days from the Delivery Date, Investor
may elect, in its sole discretion, to stop the accumulation of the Late Fees as of such date and require Company to pay to Investor
a cash amount equal to (i) the total amount of all Late Fees that have accumulated prior to the date of Investor’s election,
plus (ii) the product of the number of Delivery Shares deliverable to Investor on such date if it were to exercise this Warrant
with respect to the remaining number of Exercise Shares as of such date multiplied by the closing price of the Common Stock on
the Delivery Date (the “Cash Settlement Amount”). At such time that Investor makes an election to require Company
to pay to it the Cash Settlement Amount, such obligation of Company shall be a valid and binding obligation of Company and shall
for all purposes be deemed to be a debt obligation of Company owed to Investor as of the date it makes such election. Upon Company’s
payment of the Cash Settlement Amount to Investor, the Warrant shall be deemed to have been satisfied and Investor shall return
the original Warrant to Company for cancellation. In addition, and for the avoidance of doubt, even if Company could not deliver
the number of Delivery Shares deliverable to Investor if it were to exercise this Warrant with respect to the remaining number
of Exercise Shares on the date of repayment due to the provisions of Section 2.2, the provisions of Section 2.2 will not apply
with respect to Company’s payment of the Cash Settlement Amount.

 

(f)               
Investor shall be deemed to be the holder of the Delivery Shares issuable to it in accordance with the provisions of this Section
2.1 on the Exercise Date.

 

2.2.           
Ownership Limitation. Notwithstanding anything to the contrary contained in this Warrant or the other Transaction Documents,
if at any time Investor shall or would be issued shares of Common Stock under any of the Transaction Documents, but such issuance
would cause Investor (together with its affiliates) to own a number of shares exceeding 4.99% of the number of shares of Common
Stock outstanding on such date (the “Maximum Percentage”), Company must not issue to Investor shares of the
Common Stock which would exceed the Maximum Percentage. The shares of Common Stock issuable to Investor that would cause the Maximum
Percentage to be exceeded are referred to herein as the “Ownership Limitation Shares”. Company
will reserve the Ownership Limitation Shares for the exclusive benefit of Investor. From time to time, Investor may notify Company
in writing of the number of the Ownership Limitation Shares that may be issued to Investor without causing Investor to exceed
the Maximum Percentage. Upon receipt of such notice, Company shall be unconditionally obligated to immediately issue such designated
shares to Investor, with a corresponding reduction in the number of the Ownership Limitation Shares. Notwithstanding the forgoing,
the term “4.99%” above shall be replaced with “9.99%” at such time as the Market Capitalization of the
Common Stock is less than $10,000,000.00. Notwithstanding any other provision contained herein, if the term “4.99%”
is replaced with “9.99%” pursuant to the preceding sentence, such change to “9.99%” shall be permanent.
For purposes of this Warrant, the term “Market Capitalization of the Common Stock” shall mean the product equal
to (A) the average VWAP (as defined in the Note) of the Common Stock for the immediately preceding fifteen (15) Trading Days,
multiplied by (B) the aggregate number of outstanding shares of Common Stock as reported on Company’s most recently filed
Form 10-Q or Form 10-K. By written notice to Company, Investor may increase, decrease or waive the Maximum Percentage as to itself
but any such waiver will not be effective until the 61st day after delivery thereof. The foregoing 61-day notice requirement is
enforceable, unconditional and non-waivable and shall apply to all affiliates and assigns of Investor.

 

    	2

    	 

    

 

3.                 
Mutilation or Loss of Warrant. Upon receipt by Company of evidence satisfactory to it of the loss, theft, destruction or
mutilation of this Warrant, and (in the case of loss, theft or destruction) receipt of reasonably satisfactory indemnification,
and (in the case of mutilation) upon surrender and cancellation of this Warrant, Company will execute and deliver to Investor
a new Warrant of like tenor and date and any such lost, stolen, destroyed or mutilated Warrant shall thereupon become void.

 

4.                 
Rights of Investor. Investor shall not, by virtue of this Warrant alone, be entitled to any rights of a stockholder in
Company, either at law or in equity, and the rights of Investor with respect to or arising under this Warrant are limited to those
expressed in this Warrant and are not enforceable against Company except to the extent set forth herein.

 

5.                 
Protection Against Dilution and Other Adjustments.

 

5.1.           
Capital Adjustments. If Company shall at any time prior to the expiration of this Warrant subdivide the Common Stock, by
split-up or stock split, or otherwise, or combine its Common Stock, or issue additional shares of its Common Stock as a dividend,
the number of Warrant Shares issuable upon the exercise of this Warrant shall forthwith be automatically increased proportionately
in the case of a subdivision, split or stock dividend, or proportionately decreased in the case of a combination. Appropriate
adjustments shall also be made to the Exercise Price, Conversion Price (in the event of a cashless exercise), and other applicable
amounts, but the aggregate purchase price payable for the total number of Warrant Shares purchasable under this Warrant (as adjusted)
shall remain the same. Any adjustment under this Section 5.1 shall become effective automatically at the close of business
on the date the subdivision or combination becomes effective, or as of the record date of such dividend, or in the event that
no record date is fixed, upon the making of such dividend.

 

5.2.           
Reclassification, Reorganization and Consolidation. In case of any reclassification, capital reorganization, or change
in the capital stock of Company (other than as a result of a subdivision, combination, or stock dividend provided for in Section 5.1
above), then Company shall make appropriate provision so that Investor shall have the right at any time prior to the expiration
of this Warrant to purchase, at a total price equal to that payable upon the exercise of this Warrant, the kind and amount of
shares of stock and other securities and property receivable in connection with such reclassification, reorganization, or change
by a holder of the same number of shares of Common Stock as were purchasable by Investor immediately prior to such reclassification,
reorganization, or change. In any such case appropriate provisions shall be made with respect to the rights and interest of Investor
so that the provisions hereof shall thereafter be applicable with respect to any shares of stock or other securities and property
deliverable upon exercise hereof, and appropriate adjustments shall be made to the purchase price per Warrant Share payable hereunder,
provided the aggregate purchase price shall remain the same.

 

5.3.           
Subsequent Equity Sales. If Company or any subsidiary thereof, as applicable, at any time and from time to time while this
Warrant is outstanding, shall sell or grant any option to purchase, or sell or grant any right to reprice, or otherwise dispose
of, sell or issue (or announce any offer, sale, grant or any option to purchase or other disposition of) any Common Stock (including
any Common Stock issued under the Note, whether upon any type of conversion or any Deemed Issuance (as defined in the Note)),
preferred shares convertible into Common Stock, or debt, warrants, options or other instruments or securities which are convertible
into or exercisable for shares of Common Stock (together herein referred to as “Equity Securities”), at an
effective price per share less than the Exercise Price (such lower price, the “Base Share Price” and such issuance
collectively, a “Dilutive Issuance”) (if the holder of the Common Stock or Equity Securities so issued shall
at any time, whether by operation of purchase price adjustments, reset provisions, floating conversion, exercise or exchange prices
or otherwise, or due to warrants, options, or rights per share which are issued in connection with such issuance, be entitled
to receive shares of Common Stock at an effective price per share that is less than the Exercise Price, such issuance shall be
deemed to have occurred for less than the Exercise Price on such date of the Dilutive Issuance), then (a) the Exercise Price shall
be reduced and only reduced to equal the Base Share Price, and (b) the number of Warrant Shares issuable upon the exercise of
this Warrant shall be increased to an amount equal to the number of Warrant Shares Investor could purchase hereunder for an aggregate
Exercise Price, as reduced pursuant to subsection (a) above, equal to the aggregate Exercise Price payable immediately prior to
such reduction in Exercise Price, provided that the increase in the number of Exercise Shares issuable under to this Warrant made
pursuant to this Section 5.3 shall not at any time exceed a number equal to three (3) times the number of Exercise Shares issuable
under this Warrant as of the Issue Date (for the avoidance of doubt, the foregoing cap on the number of Exercise Shares issuable
hereunder shall only apply to adjustments made pursuant to this Section 5.3 and shall not apply to adjustments made pursuant to
Sections 5.1, 5.2 or any other section of this Warrant). Such adjustments shall be made whenever such Common Stock or Equity Securities
are issued. Company shall notify Investor, in writing, no later than the Trading Day following the issuance of any Common Stock
or Equity Securities subject to this Section 5.3, indicating therein the applicable issuance price, or applicable reset price,
exchange price, conversion price, or other pricing terms (such notice, the “Dilutive Issuance Notice”).
For purposes of clarification, whether or not Company provides a Dilutive Issuance Notice pursuant to this Section 5.3, upon the
occurrence of any Dilutive Issuance, after the date of such Dilutive Issuance, Investor is entitled to receive the increased number
of Warrant Shares provided for in subsection (b) above at an Exercise Price equal to the Base Share Price regardless of whether
Investor accurately refers to the Base Share Price in the Notice of Exercise. Additionally, following the occurrence of a Dilutive
Issuance, all references in this Warrant to “Warrant Shares” shall be a reference to the Warrant Shares as increased
pursuant to subsection (b) above, and all references in this Warrant to “Exercise Price” shall be a reference to the
Exercise Price as reduced pursuant to subsection (a) above, as the same may occur from time to time hereunder.

 

5.4.           
Notice of Adjustment. Without limiting any other provision contained herein, when any adjustment is required to be made
in the number or kind of shares purchasable upon exercise of this Warrant, or in the Exercise Price, pursuant to the terms hereof,
Company shall promptly notify Investor of such event and of the number of Warrant Shares or other securities or property thereafter
purchasable upon exercise of this Warrant.

 

5.5.           
Exceptions to Adjustment. Notwithstanding the provisions of Sections 5.3 and 5.4, no adjustment to the Exercise Price shall
be effected as a result of an Excepted Issuance. “Excepted Issuances” shall mean, collectively, (a) Company’s
issuance of securities in connection with strategic license agreements and other partnering arrangements so long as any such issuances
are not for the purpose of raising capital and in which holders of such securities or debt are not at any time granted registration
rights, and (b) Company’s issuance of Common Stock or the issuance or grant of options to purchase Common Stock to employees,
directors, officers and consultants, authorized by Company’s board of directors pursuant to plans or agreements which are
authorized, constituted or in effect as of the Issue Date.

 

6.                 
Certificate as to Adjustments. In each case of any adjustment or readjustment in the shares of Common Stock issuable on
the exercise of this Warrant, Company at its expense will promptly cause its Chief Financial Officer or other appropriate designee
to compute such adjustment or readjustment in accordance with the terms of this Warrant and prepare a certificate setting forth
such adjustment or readjustment and showing in detail the facts upon which such adjustment or readjustment is based, including
a statement of (a) the consideration received or receivable by Company for any additional shares of Common Stock issued or sold
or deemed to have been issued or sold, (b) the number of shares of Common Stock outstanding or deemed to be outstanding, and (c)
the Exercise Price and the number of shares of Common Stock to be received upon exercise of this Warrant, in effect immediately
prior to such adjustment or readjustment and as adjusted or readjusted as provided in this Warrant. Company will forthwith mail
a copy of each such certificate to Investor and any Warrant Agent (as defined below) appointed pursuant to Section 8 hereof. Nothing
in this Section 6 shall be deemed to limit any other provision contained herein.

 

    	3

    	 

    

 

7.                 
Transfer to Comply with the Securities Act. This Warrant, and the Warrant Shares, have not been registered under the 1933
Act. None of the Warrant Shares may be sold, transferred, pledged or hypothecated without (a) an effective registration statement
under the 1933 Act relating to such security or (b) an opinion of counsel reasonably satisfactory to Company that registration
is not required under the 1933 Act; provided, however, that the foregoing restrictions on transfer shall not apply to the
transfer of any security to an affiliate of Investor. Until such time as registration has occurred under the 1933 Act, each certificate
for this Warrant and any Warrant Shares shall contain a legend, in form and substance satisfactory to counsel for Company, setting
forth the restrictions on transfer contained in this Section 7; provided, however, that Company acknowledges and agrees
that any such legend shall be removed from all certificates for DTC Eligible Common Stock delivered hereunder as such Common Stock
is cleared and converted into electronic shares by the DTC (as defined in the Note), and nothing contained herein shall be interpreted
to the contrary. Any such transfer shall be accompanied by a transferor assignment substantially in the form attached to this
Warrant as Exhibit B (the “Transferor Assignment”), executed by the transferor and the transferee and
submitted to Company. Upon receipt of the duly executed Transferor Assignment, Company shall register the transferee thereon as
the new holder on the books and records of Company and such transferee shall be deemed a “registered holder” or “registered
assign” for all purposes hereunder, and shall have all the rights of Investor.

 

8.                 
Warrant Agent. Company may, by written notice to Investor, appoint an agent (a “Warrant Agent”) for
the purpose of issuing shares of Common Stock on the exercise of this Warrant pursuant hereto, exchanging this Warrant pursuant
hereto, and replacing this Warrant pursuant hereto, or any of the foregoing, and thereafter any such issuance, exchange or replacement,
as the case may be, shall be made at such office by such Warrant Agent.

 

9.                 
Transfer on Company’s Books. Until this Warrant is transferred on the books of Company, Company may treat Investor
as the absolute owner hereof for all purposes, notwithstanding any notice to the contrary.

 

10.             
Notices. Any notice required or permitted hereunder shall be given in the manner provided in the subsection titled “Notices”
in the Purchase Agreement, the terms of which are incorporated herein by reference.

 

11.             
Supplements and Amendments; Whole Agreement. This Warrant may be amended or supplemented only by an instrument in writing
signed by the parties hereto. This Warrant, together with the Purchase Agreement and all the other Transaction Documents, taken
together, contain the full understanding of the parties hereto with respect to the subject matter hereof and thereof and there
are no representations, warranties, agreements or understandings with respect to the subject matter hereof and thereof other than
as expressly contained herein and therein.

 

12.             
Governing Law. This Warrant shall be governed by and interpreted in accordance with the laws of the State of Utah, without
giving effect to the principles thereof regarding the conflict of laws.

 

13.             
Waiver of Jury Trial. COMPANY IRREVOCABLY WAIVES ANY AND ALL RIGHTS IT MAY HAVE TO DEMAND THAT ANY ACTION, PROCEEDING
OR COUNTERCLAIM ARISING OUT OF OR IN ANY WAY RELATED TO THIS WARRANT OR THE RELATIONSHIPS OF THE PARTIES HERETO BE TRIED BY JURY.
THIS WAIVER EXTENDS TO ANY AND ALL RIGHTS TO DEMAND A TRIAL BY JURY ARISING UNDER COMMON LAW OR ANY APPLICABLE STATUTE, LAW, RULE
OR REGULATION. FURTHER, COMPANY ACKNOWLEDGES THAT IT IS KNOWINGLY AND VOLUNTARILY WAIVING ITS RIGHT TO DEMAND TRIAL BY JURY.

 

14.             
Purchase Agreement; Arbitration of Disputes. This Warrant is subject to the terms, conditions and general provisions of
the Purchase Agreement and the other Transaction Documents, including without limitation the Arbitration Provisions set forth
as an Exhibit to the Purchase Agreement.

 

15.             
Remedies. The remedies at law of Investor under this Warrant in the event of any default or threatened default by Company
in the performance of or compliance with any of the terms of this Warrant are not and will not be adequate and, without limiting
any other remedies available to Investor in the Transaction Documents, at law or equity, to the fullest extent permitted by law,
such terms may be specifically enforced by a decree for the specific performance of any agreement contained herein or by an injunction
against a violation of any of the terms hereof or otherwise.

 

16.             
Counterparts. This Warrant may be executed in any number of counterparts and each of such counterparts shall for all purposes
be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument. Signatures delivered
via facsimile or email shall be considered original signatures for all purposes hereof.

 

17.             
Attorneys’ Fees. In the event of any arbitration, litigation or dispute arising from this Warrant, the parties agree
that the party who is awarded the most money shall be deemed the prevailing party for all purposes and shall therefore be entitled
to an additional award of the full amount of the attorneys’ fees and expenses paid by said prevailing party in connection
with arbitration or litigation without reduction or apportionment based upon the individual claims or defenses giving rise
to the fees and expenses. Nothing herein shall restrict or impair an arbitrator’s or a court’s power to award
fees and expenses for frivolous or bad faith pleading.

 

18.             
Severability. Whenever possible, each provision of this Warrant shall be interpreted in such a manner as to be effective
and valid under applicable law, but if any provision of this Warrant shall be invalid or unenforceable in any jurisdiction, such
provision shall be modified to achieve the objective of the parties to the fullest extent permitted and such invalidity or unenforceability
shall not affect the validity or enforceability of the remainder of this Warrant or the validity or enforceability of this Warrant
in any other jurisdiction.

 

19.             
Time of the Essence. Time is expressly made of the essence with respect to each and every provision of this Warrant.

 

20.             
Descriptive Headings. Descriptive headings of the sections of this Warrant are inserted for convenience only and shall
not control or affect the meaning or construction of any of the provisions hereof.

 

[Remainder
of page intentionally left blank; signature page follows]

 

    	4

    	 

    

 

IN
WITNESS WHEREOF, Company has caused this Warrant to be duly executed by an officer thereunto duly authorized as of the Issue Date.

 

COMPANY:

 

Endeavor
IP, Inc.

 

 

By:

Printed
Name: 

Title:

 

    	5

    	 

    

 

EXHIBIT
A

 

NOTICE
OF EXERCISE OF WARRANT

 

TO:ENDEAVOR
IP, INC.

ATTN:
_______________

VIA
FAX TO: ( )______________

 

The
undersigned hereby irrevocably elects to exercise the right, represented by the Warrant to Purchase Shares of Common Stock dated
as of July 16, 2014 (the “Warrant”), to purchase   shares of the common stock, $0.0001 par value (“Common
Stock”), of ENDEAVOR IP, INC., and tenders herewith payment in accordance with Section 2 of the Warrant, as follows:

 

_______CASH:
$__________________________ = (Exercise Price x Delivery Shares)

 

 _____  Payment
is being made by:

 

_____
enclosed check

_____wire
transfer

_____other

 

_______CASHLESS
EXERCISE:

 

Net
number of Delivery Shares to be issued to Investor: ______*

 

*
based on:Current Market Value - (Exercise Price x Exercise Shares)

Adjusted
Price of the Common Stock

 

Where:

 

Market
Price of the Common Stock [“MP”]  =$____________

 

Exercise
Shares  =_____________

 

Current
Market Value [MP x Exercise Shares]  =$________

 

Exercise
Price  =$____________

 

Adjusted
Price of the Common Stock =$____________

 

    	6

    	 

    

 

Capitalized
terms used but not otherwise defined herein shall have the meanings ascribed to them in the Warrant.

 

It
is the intention of Investor to comply with the provisions of Section 2.2 of the Warrant regarding certain limits on Investor’s
right to receive shares thereunder. Investor believes this exercise complies with the provisions of such Section 2.2. Nonetheless,
to the extent that, pursuant to the exercise effected hereby, Investor would receive more shares of Common Stock than permitted
under Section 2.2, Company shall not be obligated and shall not issue to Investor such excess shares until such time, if ever,
that Investor could receive such excess shares without violating, and in full compliance with, Section 2.2 of the Warrant.

 

As
contemplated by the Warrant, this Notice of Exercise is being sent by facsimile to the fax number and officer indicated above.

 

If
this Notice of Exercise represents the full exercise of the outstanding balance of the Warrant, Investor will surrender (or cause
to be surrendered) the Warrant to Company at the address indicated above by express courier within five (5) Trading Days after
the Warrant Shares to be delivered pursuant to this Notice of Exercise have been delivered to Investor.

 

So
that DTC processing can begin, please deliver, via reputable overnight courier, a certificate representing DTC Eligible Common
Stock equal in number to the Delivery Shares to:

 

Name:
______________________________________

Address:
_____________________________________

_____________________________________

 

To
the extent the Delivery Shares are not DTC Eligible, please deliver a certificate representing non-DTC Eligible Common Stock equal
in number to the Delivery Shares to the party and address set forth immediately above.

  

Dated:_____________________

 

___________________________

[Name
of Investor]

 

By:________________________

 

    	7

    	 

    

 

EXHIBIT
B

 

FORM
OF TRANSFEROR ENDORSEMENT

(To
be signed only on transfer of the Warrant)

 

For
value received, the undersigned hereby sells, assigns, and transfers unto the person(s) named below under the heading “Transferees”
the right represented by the Warrant to Purchase Shares of Common Stock dated as of July 16, 2014 (the “Warrant”)
to purchase the percentage and number of shares of common stock, $0.0001 par value (“Common Stock”), of ENDEAVOR
IP, INC. specified under the headings “Percentage Transferred” and “Number Transferred,” respectively,
opposite the name(s) of such person(s), and appoints each such person attorney-in-fact to transfer the undersigned’s respective
right on the books of ENDEAVOR IP, INC. with full power of substitution.

 

TransfereesPercentage
Transferred  Number Transferred

 

 

Dated:___________,
______

 

______________________________

[Transferor
Name must conform to the name of Investor as specified on the face of the Warrant]

 

By:
___________________________

Name:
_________________________

 

Signed
in the presence of:

 

_________________________

(Name)

 

 

ACCEPTED
AND AGREED:

 

_________________________

[TRANSFEREE]

 

By:
_______________________

Name:
_____________________

 

    	8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00233-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00233-of-00352.parquet"}]]